Since DCs delivery CD4+ T cell help to CD8+ T cells, several studies have initiated DC‐based vaccine pulsed by the HER2 MHC‐II epitopes366, 404, 405 and these vaccine strategies mediate tumor elimination.366, 405. This evidence concerns the gene CD8A and neoplasm.